SkylineDx today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice Guidelines in Oncology for Cutaneous Melanoma (Version 1.2026), recognizing Merlin ...
Please provide your email address to receive an email when new articles are posted on . The Merlin test, a clinical-pathologic and gene expression profile, was able to successfully classify 37% of ...
BOSTON & MOJAVE, Calif.--(BUSINESS WIRE)--Merlin, the leading developer of safe, autonomous flight technology for fixed-wing aircraft, today announced it successfully began the flight test campaign of ...
Merlin’s autonomous flight system will initially be used to assist the single pilot in a Caravan on cargo routes. Credit: Merlin U.S. startup Merlin has received an experimental airworthiness ...
BOSTON--(BUSINESS WIRE)--Merlin, the leading developer of assured autonomous flight technology for fixed-wing aircraft, today announced it’s rapidly progressing the flight test campaign of its ...
The study assessed the overall diagnostic accuracy of the Merlin CP-GEP Test for predicting sentinel node metastases and recurrence risk The Merlin CP-GEP Test demonstrated strong predictive and ...
Space Exploration Technologies Corp. (SpaceX) announced today that it has completed the qualification testing program of its Merlin 1C next generation liquid fueled rocket booster engine for use in ...
Merlin CP-GEP is the only molecular test recognized by NCCN as predictive and appropriate for use in select T1 and T2 patients to support shared decision-making regarding Sentinel Lymph Node ...